Cancer

bacteria microbiome
July 5, 2017

Bile acids, microbiota and colon cancer

Bile acids produced by a western diet alter the composition of the gut microbiota and promote intestinal carcinogenesis.

By Leigh MacMillan
June 29, 2017

Genetics of lung cancer survival

Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans.

By Sanjay Mishra
bees
June 19, 2017

STINGing combination for cancer

A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.

By VUMC News and Communications
June 13, 2017

Cancer patient chooses Nashville for VICC care and the Nashville Predators

Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville – the first was to support her favorite hockey team and the second was to meet a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center.

By VUMC News and Communications
June 8, 2017

Coffey lands major NCI award to support colorectal cancer research

Vanderbilt’s Robert Coffey Jr., M.D., has received an Outstanding Investigator Award from the National Cancer Institute (NCI) — more than $6.6 million over seven years — to support studies aimed at advancing the diagnosis and treatment of colorectal cancer (CRC), a leading cancer killer.

By Bill Snyder
June 8, 2017

Project reveals importance of cancer gene mutation testing

An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.

By VUMC News and Communications
May 17, 2017

Blood type link to cancer survival

Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study.
By Bill Snyder
May 4, 2017

Study seeks to reverse precancerous stomach lesions

Vanderbilt University Medical Center cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions.
By Bill Snyder
April 21, 2017

Ingram family honors father with $20 million gift to Vanderbilt’s College Halls

Three Ingram family members are making gifts totaling $20 million to name Vanderbilt University’s newest College Hall in honor of their late father and former Board of Trust member, E. Bronson Ingram.
By VUMC News and Communications
April 20, 2017

Study examines new breast cancer drug combination

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.
By VUMC News and Communications
April 20, 2017

Prostate cancer screening recommendations altered for some older men

A federal task force has changed its recommendation about prostate cancer screening for some older men. The United States Preventive Services Task Force (USPSTF) now recommends that men between the ages of 55 to 69 consult with their physicians about getting routine screening blood tests to detect prostate cancer.
By VUMC News and Communications
March 30, 2017

Horn to lead lung cancer combination therapy trial

Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has been selected to lead a clinical research trial of combination therapy using two targeted drugs for the treatment of a specific form of lung cancer.
By VUMC News and Communications
March 30, 2017

Research support

DS Services of America Inc. recently presented a $100,000 gift to Vanderbilt-Ingram Cancer Center (VICC) to support breast cancer research.
By VUMC News and Communications
1 … 41 42 43 44 45 … 71